BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34727222)

  • 21. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
    Zheng Q; Ye H; Zhong H; Wang M
    Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy.
    Wei M; Bai X; Dong Q
    Transl Cancer Res; 2022 Jun; 11(6):1630-1643. PubMed ID: 35836518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of prognosis-related hub genes of ovarian cancer through bioinformatics analyses and experimental verification.
    Yu Z; Ouyang L
    Medicine (Baltimore); 2022 Sep; 101(36):e30374. PubMed ID: 36086731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
    Gui T; Yao C; Jia B; Shen K
    PLoS One; 2021; 16(6):e0253136. PubMed ID: 34143800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common and specific gene signatures among three different endometriosis subtypes.
    Jiang L; Zhang M; Wang S; Han Y; Fang X
    PeerJ; 2020; 8():e8730. PubMed ID: 32185115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
    Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
    Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of PDZ Binding Kinase as a Potential Prognostic and Diagnostic Biomarker in Ovarian Cancer.
    Li C; Lyu Y; Liu C; Yin S
    Cancer Biother Radiopharm; 2022 Sep; 37(7):569-579. PubMed ID: 33794097
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of critical genes associated with poor prognosis in breast cancer via integrated bioinformatics analyses.
    Liu D; Zhang J; Li L; Wang Q; Lan Y
    J BUON; 2020; 25(6):2537-2545. PubMed ID: 33455094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
    Yu-Jing T; Wen-Jing T; Biao T
    Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.